Terbinafine-induced Toxic Epidermal Necrolysis in Pregnancy: A Case Report

JNMA J Nepal Med Assoc. 2023 Apr 1;61(260):379-382. doi: 10.31729/jnma.8116.

Abstract

Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on pregnancy outcomes. Common etiology of the condition includes medication triggered followed by mycoplasma infection. Almost one-third of cases are idiopathic. Despite the rarity of data, terbinafine causing toxic epidermal necrolysis has been reported. Toxic epidermal necrolysis manifests as a macule, erythema followed by a blister in the chest and spreading to other parts of the body. Removal of the offending agent and supportive management is the cornerstone of management. Here we report 22-year-old primipara pregnant women presenting with toxic epidermal necrolysis after 3 weeks of oral terbinafine use with good pregnancy outcomes.

Keywords: case reports; pregnancy; Stevens-Johnson syndrome; toxic epidermal necrolysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Pregnancy
  • Rare Diseases / complications
  • Stevens-Johnson Syndrome* / diagnosis
  • Stevens-Johnson Syndrome* / etiology
  • Terbinafine / adverse effects
  • Young Adult

Substances

  • Terbinafine